Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,44 € ↑0,88 (1,88%)
2026-06-03
AKTIENPREIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionRiverview Trust Co
Latest Disclosed Ownership1,254 shares
Latest Disclosed Value $ 76,055
Riverview Trust Co reports 14.75% decrease in ownership of BRM / Bristol-Myers Squibb Company

On May 1, 2026 - Riverview Trust Co filed a 13F-HR form disclosing ownership of 1,254 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $65,735 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 1,471 shares of Bristol-Myers Squibb Company. This represents a change in shares of -14.75% during the quarter. The current value of the position is $59,483 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-01 2026-03-31 13F Bristol-Myers Squibb Com 110122108 1,254 -217 -14.75 76 -3.80 0.0660
2026-01-26 2025-12-31 13F Bristol-Myers Squibb Com 110122108 1,471 0 0.00 79 19.70 0.0955
2025-10-22 2025-09-30 13F Bristol-Myers Squibb Com 110122108 1,471 -1,867 -55.93 66 -57.14 0.0801
2025-07-21 2025-06-30 13F Bristol-Myers Squibb Com 110122108 3,338 -497 -12.96 155 -33.91 0.1923
2025-04-11 2025-03-31 13F Bristol-Myers Squibb Com 110122108 3,835 -48 -1.24 234 6.39 0.2308
2025-02-06 2024-12-31 13F Bristol-Myers Squibb Com 110122108 3,883 511 15.15 220 25.86 0.1997
2024-10-18 2024-09-30 13F Bristol-Myers Squibb Com 110122108 3,372 -1,264 -27.26 174 -9.37 0.1530
2024-07-16 2024-06-30 13F Bristol-Myers Squibb Com 110122108 4,636 1,388 42.73 193 9.09 0.1825
2024-04-12 2024-03-31 13F Bristol-Myers Squibb Com 110122108 3,248 -1,081 -24.97 176 -20.72 0.1358
2024-01-24 2023-12-31 13F Bristol-Myers Squibb Com 110122108 4,329 0 0.00 222 -11.55 0.2260
2023-10-17 2023-09-30 13F Bristol-Myers Squibb Com 110122108 4,329 -244 -5.34 251 -14.04 0.2228
2023-07-18 2023-06-30 13F Bristol-Myers Squibb Com 110122108 4,573 -794 -14.79 292 -21.29 0.2651
2023-04-20 2023-03-31 13F Bristol-Myers Squibb Com 110122108 5,367 0 0.00 372 0.3419
2023-01-26 2022-12-31 13F Bristol-Myers Squibb Com 110122108 5,367 -657 -10.91 0 -100.00 0.3652
2022-10-27 2022-09-30 13F Bristol-Myers Squibb Com 110122108 6,024 887 17.27 428 8.08 0.4143
2022-07-27 2022-06-30 13F Bristol-Myers Squibb Com 110122108 5,137 0 0.00 396 5.60 0.3451
2022-04-21 2022-03-31 13F Bristol-Myers Squibb Com 110122108 5,137 1,525 42.22 375 66.67 0.2781
2022-01-19 2021-12-31 13F Bristol-Myers Squibb Com 110122108 3,612 1,577 77.49 225 87.50 0.1320
2021-10-14 2021-09-30 13F Bristol-Myers Squibb Com 110122108 2,035 1,471 260.82 120 215.79 0.1270
2021-07-16 2021-06-30 13F Bristol-Myers Squibb Com 110122108 564 0 0.00 38 5.56 0.0402
2021-04-19 2021-03-31 13F Bristol-Myers Squibb Com 110122108 564 0 0.00 36 2.86 0.0402
2021-01-22 2020-12-31 13F Bristol-Myers Squibb Com 110122108 564 0 0.00 35 2.94 0.0387
2020-10-15 2020-09-30 13F Bristol-Myers Squibb Com 110122108 564 0 0.00 34 3.03 0.0391
2020-07-08 2020-06-30 13F Bristol-Myers Squibb Com 110122108 564 -63 -10.05 33 -5.71 0.0320
2020-04-15 2020-03-31 13F/A-1 Bristol-Myers Squibb Com 110122108 627 0 0.00 35 -12.50 0.0336
2020-04-15 2020-03-31 13F Bristol-Myers Squibb Com 110122108 627 0 40 21,340.6176
2020-01-10 2019-12-31 13F Bristol-Myers Squibb Com 110122108 627 0 0.00 40 25.00 0.0269
2019-10-16 2019-09-30 13F Bristol-Myers Squibb Com 110122108 627 0 0.00 32 14.29 0.0223
2019-07-12 2019-06-30 13F Bristol-Myers Squibb Com 110122108 627 0 0.00 28 -6.67 0.0197
2019-04-10 2019-03-31 13F Bristol-Myers Squibb Com 110122108 627 0 0.00 30 -9.09 0.0227
2019-02-11 2018-12-31 13F Bristol-Myers Squibb COM 110122108 627 627 33 0.0258
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.